Home Sequencing Next-Generation Sequencing X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results

JPM - Press Release - NashBio (1) — Illumina has unveiled new technologies intended to enhance future next-generation sequencing solutions, along with numerous collaborations and updates, including a preview of results that CEO Francis deSouza said reflected a “very strong” fourth quarter and “exceptional” 2021. [Illumina]

X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results

At J.P. Morgan conference, Illumina shares new sequencing-by-synthesis chemistry and gears up for its long-read Infinity launch later this year, plus numerous collaborations and numbers that beat Wall Street expectations.

By Alex Philippidis

January 12, 2022

Illumina has unveiled new technologies intended to enhance future next-generation sequencing solutions, along with numerous collaborations and updates, including a preview of results that CEO Francis deSouza said reflected a “very strong” fourth quarter and “exceptional” 2021. [Illumina]

Illumina CEO Francis deSouza disclosed that his company has developed a new sequencing-by-synthesis (SBS) chemistry—codenamed “Chemistry X” pending a permanent name. He said Chemistry X will deliver 2x faster cycle times, as well as 2x longer reads, and 3x greater accuracy than the company’s current SBS chemistry. Additional details of Chemistry X are expected to emerge this fall, when Illumina holds its annual customer/investor day . . .